Biosite(R) Incorporated to Webcast Presentation of Early Investigational Data at International Symposium on Intensive Care and Emergency Medicine

Search Blogs that Mention this News Release

Click this link to view linked Bookmarking Services

Click this link to view linked Blogging Services

Biosite(R) Incorporated to Webcast Presentation of Early Investigational Data at International Symposium on Intensive Care and Emergency Medicine

    SAN DIEGO, March 14 /PRNewswire-FirstCall/ -- Biosite Incorporated
(Nasdaq: BSTE) announces the following webcast:
    What: Emanuel P. Rivers, M.D., MPH, IOM, Henry Ford Hospital, Detroit,
to present, "Clinical Utility of Biomarkers in Risk Assessment for
Community Acquired Sepsis" at the 27th International Symposium on Intensive
Care and Emergency Medicine (ISICEM), in Brussels, Belgium, March 27-30,
2007. The presentation will include selected data from Sepsis I, the
clinical training study for the Triage(R) Sepsis Panel.
    When: The presentation, "Clinical Utility of Biomarkers in Risk
Assessment for Community Acquired Sepsis," will take place March 28, 2007
from 12:00 p.m. to 12:15 p.m. (local), or 6:00 a.m. to 6:15 a.m. EDT, and
will be webcast through Biosite's website at http://www.biosite.com.
    Where:
http://mediasite.corogen.com/mediasite/viewer/?peid=89310c4b-a5de-
44c3-95d4-13f805cc651a OR http://www.biosite.com
    How: Live over the Internet -- Simply log onto the web at the address
above.
    Contact: Michelle Hickman
    Investor Relations Analyst
    Biosite Incorporated
    (858) 805-2419
    email: mhickman@biosite.com
    If you are unable to participate during the live webcast, the call will
be archived on the Biosite web site http://www.biosite.com until April 26, 2007.
    Company press releases may be found at http://www.biosite.com.
    About Biosite Incorporated
    Biosite Incorporated is a leading bio-medical company commercializing
proteomics discoveries for the advancement of medical diagnosis. The
Company's products contribute to improvements in medical care by aiding
physicians in the diagnosis of critical diseases and health conditions. The
Biosite Triage(R) rapid diagnostics are used in approximately 70 percent of
U.S. hospitals and in over 60 international markets. Information on Biosite
can be found at http://www.biosite.com.
    Biosite(R), Triage(R) and New Dimensions in Diagnosis(R) are registered
trademarks of Biosite Incorporated. The Company's logo is a trademark of
Biosite Incorporated.

SOURCE Biosite Incorporated

http://www.biosite.com/

http://www.prnewswire.com/comp/116737.html /
CONTACT:
Nadine Padilla, Vice President, Corporate &
Investor Relations of Biosite Incorporated, +1-858-805-2820,
npadilla@biosite.com